肌少症与抑郁症之间关系的研究进展

摘要/Abstract

中图分类号:

R337
R749.4

高磊, 高艳虹. 肌少症与抑郁症之间关系的研究进展[J]. 内科理论与实践, 2021, 16(06): 442-446.

参考文献56

[1]	Tournadre A, Vial G, Capel F, et al. Sarcopenia[J]. Joint Bone Spine, 2019, 86(3): 309-314. doi:S1297-319X(18)30189-1pmid:30098424
[2]	World Health Organization. Depression and other common mental disorders[EB/OL]. 2017. http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf.
[3]	中华医学会骨质疏松和骨矿盐疾病分会. 肌少症共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(3): 215-227.
[4]	Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3): 211-224. doi:10.1016/S2215-0366(18)30511-X URL
[5]	Casey DA. Depression in older adults: a treatable medical condition[J]. Prim Care, 2017, 44(3): 499-510. doi:10.1016/j.pop.2017.04.007 URL
[6]	荣健, 戈艳红, 孟娜娜, 等. 2010-2019年中国老年人抑郁症患病率的Meta分析[J]. 中国循证医学杂志, 2020, 20(1): 26-31.
[7]	Yanagita M, Willcox BJ, Masaki KH, et al. Disability and depression: investigating a complex relation using physical performance measures[J]. Am J Geriatr Psychiatry, 2006, 14(12): 1060-1068. doi:10.1097/01.JGP.0000224364.70515.12 URL
[8]	Kim NH, Kim HS, Eun CR, et al. Depression is associated with sarcopenia, not central obesity, in elderly korean men[J]. J Am Geriatr Soc, 2011, 59(11): 2062-2068. doi:10.1111/j.1532-5415.2011.03664.x URL
[9]	Brooks JM, Titus AJ, Bruce ML, et al. Depression and handgrip strength among U.S. adults aged 60 years and older from NHANES 2011-2014[J]. J Nutr Health Aging, 2018, 22(8): 938-943. doi:10.1007/s12603-018-1041-5pmid:30272097
[10]	Hsu YH, Liang CK, Chou MY, et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study[J]. Geriatr Gerontol Int, 2014, 14 Suppl 1: 102-108.
[11]	Demakakos P, Cooper R, Hamer M, et al. The bidirectional association between depressive symptoms and gait speed: evidence from the English Longitudinal Study of Ageing (ELSA)[J]. PLoS One, 2013, 8(7): e68632. doi:10.1371/journal.pone.0068632 URL
[12]	Fukumori N, Yamamoto Y, Takegami M, et al. Association between hand-grip strength and depressive symptoms: Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS)[J]. Age Ageing, 2015, 44(4): 592-598. doi:10.1093/ageing/afv013pmid:25712514
[13]	Ishii S, Chang C, Tanaka T, et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults[J]. PLoS One, 2016, 11(9): e0162898.
[14]	Chen X, Guo J, Han P, et al. Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia[J]. J Am Med Dir Assoc, 2019, 20(1): 64-69. doi:10.1016/j.jamda.2018.07.017 URL
[15]	Chang KV, Hsu TH, Wu WT, et al. Is sarcopenia associated with depression?[J]. Age Ageing, 2017, 46(5): 738-746. doi:10.1093/ageing/afx094 URL
[16]	Byeon CH, Kang KY, Kang SH, et al. Sarcopenia is not associated with depression in Korean adults: results from the 2010-2011 Korean National Health and Nutrition Examination Survey[J]. Korean J Fam Med, 2016, 37(1): 37-43. doi:10.4082/kjfm.2016.37.1.37 URL
[17]	Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise[J]. Free Radic Biol Med, 2019, 132: 42-49. doi:10.1016/j.freeradbiomed.2018.08.035 URL
[18]	Hallgren M, Herring MP, Owen N, et al. Exercise, physical activity, and sedentary behavior in the treatment of depression: broadening the scientific perspectives and clinical opportunities[J]. Front Psychiatry, 2016, 7: 36. doi:10.3389/fpsyt.2016.00036pmid:27014101
[19]	Park SS, Seo YK, Kwon KS. Sarcopenia targeting with autophagy mechanism by exercise[J]. BMB Rep, 2019, 52(1): 64-69. doi:10.5483/BMBRep.2019.52.1.292 URL
[20]	Xia Z, Cholewa J, Zhao Y, et al. Targeting inflammation and downstream protein metabolism in sarcopenia[J]. Front Physiol, 2017, 8: 434. doi:10.3389/fphys.2017.00434 URL
[21]	Hughes MM, Connor TJ, Harkin A. Stress-related immune markers in depression: implications for treatment[J]. Int J Neuropsychopharmacol, 2016, 19(6): pyw001.
[22]	Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia[J]. Front Physiol, 2017, 8: 1045. doi:10.3389/fphys.2017.01045 URL
[23]	Yoo SZ, No MH, Heo JW, et al. Role of exercise in age-related sarcopenia[J]. J Exerc Rehabil, 2018, 14(4): 551-558. doi:10.12965/jer.1836268.134 URL
[24]	Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia[J]. Int J Mol Sci, 2010, 11(4): 1509-1526. doi:10.3390/ijms11041509 URL
[25]	黄晓幸. 免疫炎症反应在抑郁症中作用的研究进展[J]. 微循环学杂志, 2020, 30(4): 78-81.
[26]	Remelli F, Vitali A, Zurlo A, et al. Vitamin D deficiency and sarcopenia in older persons[J]. Nutrients, 2019, 11(12): 2861. doi:10.3390/nu11122861 URL
[27]	Geng C, Shaikh AS, Han W, et al. Vitamin D and depression: mechanisms, determination and application[J]. Asia Pac J Clin Nutr, 2019, 28(4): 689-694.
[28]	Abiri B, Vafa M. Vitamin D and muscle sarcopenia in aging[J]. Methods Mol Biol, 2020, 2138: 29-47.
[29]	Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases[J]. Int J Mol Sci, 2018, 19(8): 2245. doi:10.3390/ijms19082245 URL
[30]	Pertile RA, Cui X, Eyles DW. Vitamin D signaling and the differentiation of developing dopamine systems[J]. Neuroscience, 2016, 333: 193-203. doi:10.1016/j.neuroscience.2016.07.020pmid:27450565
[31]	Huiberts LM, Smolders KCHJ. Effects of vitamin D on mood and sleep in the healthy population: interpretations from the serotonergic pathway[J]. Sleep Med Rev, 2021, 55: 101379. doi:10.1016/j.smrv.2020.101379 URL
[32]	Zhang WY, Guo YJ, Wang KY, et al. Neuroprotective effects of vitamin D and 17β-estradiol against ovariectomy-induced neuroinflammation and depressive-like state[J]. Int Immunopharmacol, 2020, 86: 106734. doi:10.1016/j.intimp.2020.106734 URL
[33]	Dupont J, Dedeyne L, Dalle S, et al. The role of omega-3 in the prevention and treatment of sarcopenia[J]. Aging Clin Exp Res, 2019, 31(6): 825-836. doi:10.1007/s40520-019-01146-1pmid:30784011
[34]	Deacon G, Kettle C, Hayes D, et al. Omega 3 polyunsaturated fatty acids and the treatment of depression[J]. Crit Rev Food Sci Nutr, 2017, 57(1): 212-223. doi:10.1080/10408398.2013.876959 URL
[35]	Wei Y, Meng Y, Li N, et al. The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis[J]. Food Funct, 2021, 12(1): 30-40. doi:10.1039/D0FO01976C URL
[36]	van Dronkelaar C, van Velzen A, Abdelrazek M, et al. Minerals and sarcopenia; the role of calcium, iron, magnesium, phosphorus, potassium, selenium, sodium, and zinc on muscle mass, muscle strength, and physical performance in older adults[J]. J Am Med Dir Assoc, 2018, 19(1): 6-11. doi:S1525-8610(17)30305-5pmid:28711425
[37]	Wang J, Um P, Dickerman BA, et al. Zinc, magnesium, selenium and depression: a review of the evidence, potential mechanisms and implications[J]. Nutrients, 2018, 10(5): 584. doi:10.3390/nu10050584 URL
[38]	Ikeda K, Horie-Inoue K, Inoue S. Functions of estrogen and estrogen receptor signaling on skeletal muscle[J]. J Steroid Biochem Mol Biol, 2019, 191: 105375. doi:10.1016/j.jsbmb.2019.105375 URL
[39]	Albert KM, Newhouse PA. Estrogen, stress, and depression: cognitive and biological interactions[J]. Annu Rev Clin Psychol, 2019, 15: 399-423. doi:10.1146/annurev-clinpsy-050718-095557 URL
[40]	Georgakis MK, Thomopoulos TP, Diamantaras AA, et al. Association of age at menopause and duration of reproductive period with depression after menopause[J]. JAMA Psychiatry, 2016, 73(2): 139-149. doi:10.1001/jamapsychiatry.2015.2653pmid:26747373
[41]	MacNeil LG, Baker SK, Stevic I, et al. 17β-estradiol attenuates exercise-induced neutrophil infiltration in men[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 300(6): R1443-R1451. doi:10.1152/ajpregu.00689.2009 URL
[42]	Yamada Y, Tada M, Mandai K, et al. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study[J]. Clin Rheumatol, 2020, 39(6): 1757-1764. doi:10.1007/s10067-020-04929-4 URL
[43]	Hong N, Lee J, Ku CR, et al. Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism[J]. Clin Endocrinol (Oxf), 2019, 90(2): 267-276. doi:10.1111/cen.13902 URL
[44]	Dean J, Keshavan M. The neurobiology of depression[J]. Asian J Psychiatr, 2017, 27: 101-111. doi:10.1016/j.ajp.2017.01.025 URL
[45]	Shah OJ, Kimball SR, Jefferson LS. Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle[J]. Am J Physiol Endocrinol Metab, 2000, 278(1): E76-E82. doi:10.1152/ajpendo.2000.278.1.E76 URL
[46]	Martín AI, Priego T, López-Calderón A. Hormones and muscle atrophy[J]. Adv Exp Med Biol, 2018, 1088: 207-233.
[47]	Cid-Díaz T, Santos-Zas I, González-Sánchez J, et al. Obestatin controls the ubiquitin-proteasome and auto-phagy-lysosome systems in glucocorticoid-induced muscle cell atrophy[J]. J Cachexia Sarcopenia Muscle, 2017, 8(6): 974-990. doi:10.1002/jcsm.12222pmid:28675664
[48]	Lützner N, Kalbacher H, Krones-Herzig A, et al. FOXO 3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop[J]. PLoS One, 2012, 7(7): e42166. doi:10.1371/journal.pone.0042166 URL
[49]	Dwyer JB, Aftab A, Radhakrishnan R, et al. Hormonal treatments for major depressive disorder: state of the art[J]. Am J Psychiatry, 2020, 177(8): 686-705. doi:10.1176/appi.ajp.2020.19080848 URL
[50]	Bloise FF, Oliveira TS, Cordeiro A, et al. Thyroid hormones play role in sarcopenia and myopathies[J]. Front Physiol, 2018, 9: 560. doi:10.3389/fphys.2018.00560 URL
[51]	倪敏, 吴琪. 甲状腺激素与抑郁症相关性分析[J]. 中国现代医生, 2020, 58(10): 15-18.
[52]	Milanesi A, Lee JW, Yang A, et al. Thyroid hormone receptor alpha is essential to maintain the satellite cell niche during skeletal muscle injury and sarcopenia of aging[J]. Thyroid, 2017, 27(10): 1316-1322. doi:10.1089/thy.2017.0021pmid:28847239
[53]	Larsson L, Müller U, Li X, et al. Thyroid hormone regulation of myosin heavy chain isoform composition in young and old rats, with special reference to ⅡⅩ myosin[J]. Acta Physiol Scand, 1995, 153(2): 109-116. pmid:7778450
[54]	Pak K, Kim M, Kim K, et al. Cerebral glucose metabolism and cerebral blood flow in thyroid dysfunction[J]. Sci Rep, 2020, 10(1): 1335. doi:10.1038/s41598-020-58255-5 URL
[55]	Fukao A, Takamatsu J, Arishima T, et al. Graves’ disease and mental disorders[J]. J Clin Transl Endocrinol, 2020, 19: 100207.
[56]	张音, 沈宏华, 许轶明, 等. 肌少症的诊断与治疗研究进展[J]. 内科理论与实践, 2021, 16(3): 220-224.

肌少症与抑郁症之间关系的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献56

相关文章15

编辑推荐

Metrics

本文评价

[1]	郑毓真, 郑彦俊, 周易, 祁星, 陈薇薇, 史雯, 周伟君, 杨之涛, 陈影, 毛恩强, 陈尔真.综合性医院674例脓毒症住院患者的回顾性临床分析[J]. 内科理论与实践, 2022, 17(04): 278-282.
[2]	鲍萍萍, 吴春晓, 顾凯, 庞怡, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕.上海市2016年胃癌发病特征及2002年至2016年胃癌发病趋势分析[J]. 诊断学理论与实践, 2022, 21(04): 462-469.
[3]	李菲卡, 杨文丽, 蒋倩雯, 方芳, 白婷婷, 徐刚, 吴方, 何清.基于德尔菲专家咨询法构建的老年肌少症评估初始量表[J]. 内科理论与实践, 2022, 17(03): 238-242.
[4]	陈颖, 沈虹, 林靖生, 杨之涛, 周惠娟, 蔡燕华, 毕宇芳, 宁光.高校新型冠状病毒肺炎疫情防控工作建议手册[J]. 内科理论与实践, 2022, 17(02): 174-177.
[5]	付朝伟.阿尔茨海默病重在预防——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 8-11.
[6]	吴春晓, 顾凯, 庞怡, 鲍萍萍, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕.2016年上海市甲状腺癌发病和死亡情况与2002—2016年间变化趋势分析[J]. 外科理论与实践, 2022, 27(01): 58-65.
[7]	吴春晓, 龚杨明, 顾凯, 庞怡, 鲍萍萍, 王春芳, 施亮, 向詠梅, 窦剑明, 付晨, 施燕.2016年上海市结肠直肠癌发病和死亡情况与2002—2016年间的变化趋势分析[J]. 外科理论与实践, 2021, 26(04): 325-335.
[8]	张音, 沈宏华, 许轶明, 任蕾.肌少症的诊断与治疗研究进展[J]. 内科理论与实践, 2021, 16(03): 220-224.
[9]	程挺, 钱海明, 顾伟敏, 邵桢谊, 田源, 张娟平, 程齐俭.2013—2018年上海市嘉定区需住院肺炎发病情况的分析[J]. 内科理论与实践, 2021, 16(02): 108-115.
[10]	黄丹, 陈崑.银屑病相关流行病学调查进展[J]. 诊断学理论与实践, 2021, 20(01): 48-52.
[11]	王娟, 李佳.2017年至2018年上海地区男性尖锐湿疣患者人乳头瘤病毒感染的流行病学分析[J]. 诊断学理论与实践, 2020, 19(06): 572-576.
[12]	吴春晓, 顾凯, 王春芳, 彭鹏, 龚杨明, 施亮, 向詠梅, 庞怡, 鲍萍萍.上海市女性乳腺癌流行现况、回顾与比较分析[J]. 外科理论与实践, 2019, 24(05): 421-427.
[13]	刘珊珊, 牛静雅, 王天歌, 李勉, 赵志云, 徐瑜, 陆洁莉, 徐敏, 毕宇芳, 张迪.上海淞南社区2型糖尿病患者合并其他心血管代谢异常的现况流行病学调查[J]. 诊断学理论与实践, 2019, 18(03): 323-328.
[14]	王启晗, 张中文, 吴健, 蔡强, 孙海东, 蔡劬, 蒋兆彦, 韩天权, 张圣道.上海地区胆囊结石病的流行病学调查[J]. 外科理论与实践, 2018, 23(03): 252-257.
[15]	董淑慧, 孙喜蓉, 王涛, 肖世富,.社区老年人抑郁症状的调查与分析[J]. 内科理论与实践, 2018, 13(03): 170-174.